Active Ingredient(s): Gemcitabine 0.9% + Sodium Chloride
FDA Approved: * July 16, 2018
Pharm Company: * SUN PHARM INDS INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Infugem Overview

Gemcitabine, sold under the brand name Gemzar, among others,[1] is a chemotherapy medication used to treat a number of types of cancer.[2] These cancers include breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer.[2][3] It is given by slow injection into a vein.[2] Common side effects include bone marrow suppression, liver and kidney problems, nausea, fever, rash, short...

Read more Infugem Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Infugem Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Gemcitabine 0.9% + Sodium Chloride
  • Injection: 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (22 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 September 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 501 S. Cherry St, Suite 1100, Denver, CO, 80246, USA